Abatacept Safety Outcomes Across 7 European Registries A multinational registry analysis of RA receiving abatacept (ABA) has shown that the safety profile of ABA remains unchanged with no new or increased risks of infection or malignancy. https://t.co/CVeAV0ZXA8 https://t.co/A8McLt0rSl